Company · CIK 0001842295
Maze Therapeutics, Inc.
MAZESearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$27.11+$1.23 (+4.75%)
MAZE · Last trade
- Prev close
- $25.88
- Range (29d)
- $22.39 – $28.38
On the record
Recent filings
- 144MAZEMaze Therapeutics, Inc.0001950047-26-009933 · 7.7 KBSEC(opens sec.gov)
- 144MAZEMaze Therapeutics, Inc.0001969223-26-001044 · 9.2 KBSEC(opens sec.gov)
- 144MAZEMaze Therapeutics, Inc.0001950047-26-009147 · 7.7 KBSEC(opens sec.gov)
- 144MAZEMaze Therapeutics, Inc.0001782758-26-000005 · 4.8 KBSEC(opens sec.gov)
- 144MAZEMaze Therapeutics, Inc.0002050167-26-000024 · 7.1 KBSEC(opens sec.gov)
- 144MAZEMaze Therapeutics, Inc.0001676170-26-000019 · 12.0 KBSEC(opens sec.gov)
- 144MAZEMaze Therapeutics, Inc.0002050172-26-000031 · 7.1 KBSEC(opens sec.gov)
- 144MAZEMaze Therapeutics, Inc.0001969223-26-000973 · 11.2 KBSEC(opens sec.gov)
- 8-KMAZECurrent report0001193125-26-354092 · 175.8 KBSEC(opens sec.gov)
- SCHEDULE 13G/AMAZEMaze Therapeutics, Inc.0001104659-26-097205 · 12.3 KBSEC(opens sec.gov)
Insiders
- Andrews Nancy CDirector
- ARCH Venture Fund X, L.P.10% Owner
- ARCH Venture Partners X, LLC10% Owner
- Bachrodt AmySVP, Finance
- Bernstein HaroldPresident, R&D & CMO
- Brush JamesDirector
- Burow Kristina10% Owner
- Coloma Jason VDirector, Chief Executive Officer
- Colowick AlanDirector
- Courtney PhillipsGC and Corp. Secretary
Tickers
Addresses
business
171 OYSTER POINT BOULEVARD, SUITE 300
SOUTH SAN FRANCISCO, CA, 94080
mailing
171 OYSTER POINT BOULEVARD, SUITE 300
SOUTH SAN FRANCISCO, CA, 94080
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies